Effect of topiramate on intractable seizures in Taiwanese children

Acta Neurologica Taiwanica

Volumn 13, Issue 2, 2004, Pages 59-63

  Li, Sung Tse ^a   Shen, Ein Yiao ^a,b   Chiu, Nan Chang ^a   Ho, Che Sheng ^a  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Children; Epileptic therapy; Intractable epilepsy; Topiramate

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ABSENCE; ADOLESCENT; ANTICONVULSANT THERAPY; APPETITE DISORDER; ARTICLE; CHILD; CLINICAL ARTICLE; DRUG EFFECT; FECES INCONTINENCE; FEMALE; FOCAL EPILEPSY; GENERALIZED EPILEPSY; HUMAN; HYPERVENTILATION; INFANTILE SPASM; INTRACTABLE EPILEPSY; IRRITABILITY; MALE; MYOCLONUS SEIZURE; SLURRED SPEECH; SOMNOLENCE; TAIWAN; TONIC CLONIC SEIZURE;

ADOLESCENT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FRUCTOSE; HUMANS; MALE; PROSPECTIVE STUDIES; SEIZURES;

EID: 3042794749     PISSN: 10196099     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Zupanc ML. Update on epilepsy in pediatric patients. Mayo Clin Proc 1996;71:899-916.
2. Pellock JM, Watemberg N. New antiepileptic drugs in children: present and future. Sem Pediatr Neurol 1997;4:9-18.
3. Pellock JM. Managing pediatric epilepsy syndromes with new antiepileptic drugs. Pediatrics 1999;104:1106-16.
4. Rosenfeld WE. Topiramate: a review or preclinical, pharmacokinetic, and clinical data. Clin Ther 1997;19:1294-308.
5. Rogawski MA, Porter RJ. Antiepileptic drugs: pharmacological mechanism and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol Rev 1990;42:223-86.
6. Faught E, Wilder BJ, Ramsay RE, et al. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Neurology 1996;46:1684-90.
7. Privitera M, Fincham R, Penry J, et al. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Topirmate YE Study Group. Neurology 1996;46:1678-83.
8. Sharief M, Viteri C, Ben-Menachem E, et al. Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy. Epilepsy Res 1992;25:217-24.
9. Tassinari CA, Michelucci R, Chauvel P, et al. Double-blind, placebo-controlled trial of topiramate (600mg daily) for the treatment of refractory partial epilepsy. Epilepsia 1996;37:763-8.
10. Ben-Menachem E, Henriksen O, Dam M, et al. Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures. Epilepsia 1996;37:539-43.
11. Reife R, Pledger GW, Wu SC. Topiramate as add-on therapy: pooled analysis of randomized controlled trials in adults. Epilepsia 2000;41:S66-71.
12. Glauser TA. Topiramate in the catastrophic epilepsies of childhood. J Child Neurol 2000;15:S14-21.
13. Elterman RD, Glauser TA, Wyllie E, et al. A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Neurology 1999;52:1338-44.
14. Biton V, Montouris GD, Ritter F, et al. A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Neurology 1999;52:1330-7.
15. Glauser TA, Clark PO, Strawsburg R. A pilot study of topiramate in the treatment of infantile spasms. Epilepsia 1998;39:1324-8.
16. Glauser TA, Clark PO, McGee K. Long-term response to topiramate in patients with West syndrome. Epilepsia 2000;41:S91-4.
17. Sachdeo RC, Glauser TA, Ritter F, et al. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Neurology 1999;52:1882-7.
18. Glauser TA, Levisohn PM, Ritter F, et al. Topiramate in Lennox-Gastaut syndrome: open-label treatment of patients completing a randomized controlled trial. Epilepsia 2000;41:S86-90.
19. Anonymous. Proposal for revised clinical and electroen-cephalographic classification of epileptic seizures. Commission on classification and terminology of the international league against epilepsy. Epilepsia 1981;22:489-501.
20. Anonymous. Proposal for classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1985;26:268-78.
21. Anonymous. Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1989;30:389-99.
22. Cross JH. Topiramate monotherapy for childhood absence seizures: an open label pilot study. Seizure 2002;11:406-10.
23. Bourgeois BF. New antiepileptic drugs. Arch Neurol 1998;55:1181-3.
24. Laskey AL, Korn DE, Moorjani BI, et al. Central hyperventilation related to administration of topiramate. Pediatr Neurol 2000;22:305-8.